Argenx
ARGX
#638
Rank
$31.87 B
Marketcap
$533.00
Share price
-0.62%
Change (1 day)
3.69%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: $31.87 Billion

As of September 2024 Argenx has a market cap of $31.87 Billion. This makes Argenx the world's 638th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

End of year Market Cap

Year Market cap Change
2024$31.87 B41.23%
2023$22.56 B7.67%
2022$20.95 B13.96%
2021$18.39 B31.15%
2020$14.02 B103.85%
2019$6.87 B96.18%
2018$3.50 B74.88%
2017$2.00 B
2014$0.14 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Argenx was reported to be:

$31.87 Billion
by Yahoo Finance info icon info icon
$31.87 Billion
by CompaniesMarketCap info icon info icon
$31.55 Billion
by Nasdaq info icon info icon